⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11420212 | 1.00 | SAT1 (0.60) | — | |
| Hydrochloric Acid SCHEMBL6609960 | 0.97 | — | — | |
| SCHEMBL17355046 | 0.95 | SAT1 (0.61) | — | |
| SCHEMBL24540363 | 0.91 | SAT1 (0.52) | — | |
| SCHEMBL1795740 | 0.91 | SAT1 (0.52) | — | |
| SCHEMBL5626798 | 0.90 | SAT1 (0.50) | — | |
| SCHEMBL26507012 | 0.90 | — | — | |
| SCHEMBL7877684 | 0.89 | SAT1 (0.73) | — | |
| Hydrochloric Acid SCHEMBL5379319 | 0.87 | GNAI3 (0.48) | — | |
| SCHEMBL11922715 | 0.87 | SAT1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 707 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103347866-B | As the noval chemical compound of the respiratory stimulant for the treatment of control of breathing discomfort or disease | GALLEON PHARMACEUTICALS, INC. (US) | 2016-05-18 | — | — | CN | claimed |
| CN-103347866-A | Novel compound as respiratory stimulants for treatment of breathing control disorder or disease | GALLEON PHARMACEUTICALS INC | 2013-10-09 | — | — | CN | claimed |
| US-20110288057-A1 | SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS | NOVARTIS AG (CH) | 2011-11-24 | — | — | US | claimed |
| EP-1805166-B1 | QUINOLINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2011-07-27 | — | — | EP | claimed |
| EP-2342173-A1 | SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS | Novartis AG (CH) | 2011-07-13 | — | — | EP | claimed |
| US-7790720-B2 | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses | UCB PHARMA, S.A. (BE) | 2010-09-07 | — | — | US | claimed |
| WO-2010043584-A1 | SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS | NOVARTIS AG (CH) | 2010-04-22 | — | — | WO | claimed |
| US-20080275046-A1 | Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses | UCB PHARMA, S.A. (BE) | 2008-11-06 | — | — | US | claimed |
| EP-1569911-B1 | INDAZOLE DERIVATIVES AS CRF ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2008-07-02 | — | — | EP | claimed |
| EP-1866293-A1 | COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES | UCB Pharma, S.A. (BE) | 2007-12-19 | — | — | EP | claimed |
| WO-2004069803-A2 | MONO-ACYLATED O-PHENYLENDIAMINES DERIVATIVES AND THEIR USE AGAINST CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-19 | — | — | WO | claimed |
| US-6627624-B1 | Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome, | NEUROGEN CORPORATION | 2003-09-30 | — | — | US | claimed |
| EP-1019046-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM (US) | 2002-11-27 | — | — | EP | claimed |
| US-20020049316-A1 | Protease inhibitors | HALBERT STACIE MARIE (US) | 2002-04-25 | — | — | US | claimed |
| EP-1019046-A1 | PROTEASE INHIBITORS | Smithkline Beecham (US) | 2000-07-19 | — | — | EP | claimed |
| WO-1998048799-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-05 | — | — | WO | claimed |
| US-5140022-A | Muscle relaxants | ANAQUEST, INC. (US) | 1992-08-18 | — | — | US | claimed |
| EP-0478910-A2 | 3-Substituted-aminomethyl-3-substituted-oxy-17A-methyl-17A-lower-alkyl-17A-aza-d-homo-5-alpha-androstanes | Anaquest, Inc. (US) | 1992-04-08 | — | — | EP | claimed |
| US-4275238-A | CYCLIZING BUTANEDIOL USING A COBALT CATALYST, ALKYLATING WITH PROPYLAMINE | CIBA-GEIGY CORPORATION (US) | 1981-06-23 | — | — | US | claimed |
| US-4264527-A | REACTING CYCLOPROPYLMETHYLAMINE WITH PROPIONITRILE IN THE PRESENCE OF A HYDROGENATION CATALYST AND HYDROGEN | CIBA-GEIGY CORPORATION (US) | 1981-04-28 | — | — | US | claimed |